Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
WEIGHT LOSS DRUGS COULD ADD YEARS TO AMERICANS' LIVES, RESEARCHERS PROJECT Oz predicted that President Donald Trump's deal with pharmaceutical companies will allow America to lose 135 million pounds over the next 12 months
Should be paired with lifestyle changes
We expected that patients taking the GLP-1s for obesity may have a lower cost of care and improved medical outcomes as we presumed that the weight loss could have led to a decrease in the frequency of office/hospital visits and/or the use of drugs for treatment of conditions such as hypertension, high cholesterol and osteoarthritis
These findings remain investigational pending the completion of phase 3 trials and regulatory review
Since then, several human GLP-1 RAs, such as liraglutide, dulaglutide, semaglutide, and tirzepatide, have been developed, offering enhanced pharmacokinetic properties for more convenient administration [1]
